2invest AG
Limited financial coverage for FBSBF.
Not enough data to compute a meaningful composite — typical for foreign-listed ADRs, recent IPOs, or thinly-covered small caps. Live quote, chart, and any available stats still render below.
Price Chart
About the company
Operating as an investment firm, 2invest AG engages in the acquisition, management, and ultimate sale of equity interests in corporations and partnerships. The company primarily targets the biotechnology, life science, and information technology industries, with its activities extending across Germany and internationally. This entity, headquartered in Heidelberg, Germany, adopted its current name, 2invest AG, in January 2021, having previously operated under the name 4basebio AG.
- CEO
- Nick Gee
- IPO
- 2021
- Employees
- 2
- HQ
- Heidelberg, DE
Get TickerSpark's AI analysis on FBSBF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- 52W High
- $15.50
- 52W Low
- $15.50
- 50D MA
- $15.50
- 200D MA
- $15.50
- Beta
- 0.37
- RSI (14)
- 96
- Avg Volume
- 0
No earnings-call transcripts are available for FBSBF yet.
- Free Float
- 51.7%
- Shares Outstanding
- 5.75M
- Float Shares
- 2.97M
Our FBSBF coverage
Recent articles, reports, and earnings notes.
No research on FBSBF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate FBSBF report →